• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rational therapy in RA: Issues in implementing a treat-to-target approach in RA.

作者信息

Cohen Marc D, Keystone Edward C

机构信息

University of Colorado Medical Center, Division of Rheumatology, 668 Humboldt St Denver, CO 80218, USA.

出版信息

Nat Rev Rheumatol. 2013 Mar;9(3):137-8. doi: 10.1038/nrrheum.2013.18. Epub 2013 Feb 12.

DOI:10.1038/nrrheum.2013.18
PMID:23399690
Abstract
摘要

相似文献

1
Rational therapy in RA: Issues in implementing a treat-to-target approach in RA.类风湿关节炎的合理治疗：类风湿关节炎中实施达标治疗方法的相关问题。
Nat Rev Rheumatol. 2013 Mar;9(3):137-8. doi: 10.1038/nrrheum.2013.18. Epub 2013 Feb 12.
2
Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial.在NEO-RACo试验中，医生坚持治疗达标策略对早期类风湿关节炎治疗结果的影响。
Scand J Rheumatol. 2015;44(6):449-55. doi: 10.3109/03009742.2015.1043142. Epub 2015 Aug 31.
3
Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort.坚持遵循改善病情抗风湿药物的标准化靶向强化治疗方案对类风湿关节炎治疗结果的影响：来自澳大利亚早期关节炎队列的结果
J Rheumatol. 2016 Sep;43(9):1643-9. doi: 10.3899/jrheum.151392. Epub 2016 Jul 15.
4
Rheumatoid arthritis: can we achieve true drug-free remission in patients with RA?类风湿关节炎：我们能否使类风湿关节炎患者达到真正的药物缓解？
Nat Rev Rheumatol. 2010 Feb;6(2):68-70. doi: 10.1038/nrrheum.2009.253.
5
Medication adherence and cost-related medication non-adherence in patients with rheumatoid arthritis: A cross-sectional study.类风湿关节炎患者的药物依从性及与费用相关的药物不依从性：一项横断面研究。
Int J Rheum Dis. 2019 Apr;22(4):555-566. doi: 10.1111/1756-185X.13549. Epub 2019 Mar 28.
6
A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA).一项前瞻性、单中心、随机研究，评估类风湿关节炎患者中极早期与延迟使用依那西普实现的临床、影像学和免疫学缓解深度（VEDERA研究）。
BMC Musculoskelet Disord. 2016 Feb 5;17:61. doi: 10.1186/s12891-016-0915-0.
7
Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy.强化病情缓解抗风湿药物治疗3年后早期类风湿关节炎的疾病活动轨迹：与治疗依从性的关联
Int J Rheum Dis. 2017 Oct;20(10):1447-1456. doi: 10.1111/1756-185X.13184. Epub 2017 Sep 26.
8
Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis.新型光学光谱透射（OST）指导与传统疾病活动指导治疗的比较：一项关于指导早期类风湿关节炎靶向治疗策略的随机临床试验研究方案。
Trials. 2019 Apr 17;20(1):226. doi: 10.1186/s13063-019-3285-8.
9
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register.依那西普治疗中度类风湿关节炎的疾病缓解率高：来自意大利生物制剂登记处GISEA的数据。
Clin Rheumatol. 2014 Jan;33(1):31-7. doi: 10.1007/s10067-013-2348-6. Epub 2013 Aug 18.
10
Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.使用风湿病学依从性问卷识别类风湿关节炎患者口服抗风湿药物治疗不依从风险：一项ARCO子研究
Rheumatol Int. 2017 Jul;37(7):1195-1202. doi: 10.1007/s00296-017-3737-y. Epub 2017 May 17.

本文引用的文献

1
Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort.早期类风湿关节炎采用达标治疗策略的效果：DREAM缓解诱导队列研究结果
Arthritis Res Ther. 2012 Nov 23;14(6):R254. doi: 10.1186/ar4099.
2
Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study.在早期类风湿关节炎中，增加治疗并非取决于疾病活动评分，而是取决于医生整体评估：来自 CATCH 研究的结果。
J Rheumatol. 2012 Nov;39(11):2081-7. doi: 10.3899/jrheum.120520. Epub 2012 Sep 1.
3
State-of-the-art: rheumatoid arthritis.
现状：类风湿关节炎。
Ann Rheum Dis. 2010 Nov;69(11):1898-906. doi: 10.1136/ard.2010.134684.
4
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes.疾病活动评分不适用于临床中启动和评估抗肿瘤坏死因子治疗的唯一标准：评估措施之间的不一致以及用于监管目的的问卷使用存在局限性。
Arthritis Rheum. 2005 Dec;52(12):3873-9. doi: 10.1002/art.21494.